Список использованной литературы при подготовке статей по контрастной эхокардиографии
1. Agati L, Tonti G, Pedrizzetti G et al. Clinical application of quantitative analysis in real-time MCE. Eur J Echocardiogr 2004;5(Suppl 2): 17—23.
2. Agati L, Tonti G, Galiuto L et al. Quantification methods in contrast echocardiography. Eur J Echocardiogr 2005;6(Suppl 2): 14-20.
3. Aggeli C, Stefanidis C, Bnou M et al. Prediction of functional recovery of hibernating myocardium using harmonic power Doppler imaging and dobutamine stress echocardiography in patients with coronary artery disease. Am J Cardiol 2003;91:1415-20.
4. Armstrong WF, Kinney EL, Mueller TM et al. Assessment of myocardial perfusion abnormalities with contrast enhanced two-dimensional echocardiography. Circulation 1982;66:166-73.
5. Becher H, von Bibra H. Verstarkung von Doppler Signalcn bei Aorten- und Mitralvitien. Z Kardiol 1997;86:1033-9.
6. von Bibra H, Stempfle IIU, Poll A, Schlief R, Blomer II. Echocontrast agents improve flow display of color Doppler - in vitro studies. Echocardiography 1991;8:533^10.
7. von Bibra H, Becher H, Firschke C, Schlief R, Emslander HP, Schomig A. Enhancement of mitral regurgitation and normal left atrial color Doppler flow signals with peripheral venous injection of a galactose based contrast agent. J Am Coll Cardiol 1993;22:521-8.
8. von Bibra H, Sutherland G, Becher H, Neudert J, Nihoyannopoulos P. Clinical evaluation of left heart Doppler contrast enhancement by a saccharide based trans-pulmonary contrast agent. The Levovist Cardiac Working Group. .1 Am Coll Cardiol 1995;25:500-8.
9. von Bibra H, Hansen A, Dounis V, Bystedt T, Malmberg K, Ryden L. Augmented metabolic control improves myocardial diastolic function and perfusion in patients with type 2 diabetes mellitus. Heart 2004;90:1483^1.
10. von Bibra H. Bestimmung der myokardialen Perfusion - Beitrag der Kontrast-Echokardiographie. Z Kardiol 2001;90:848-59.
11. von Bibra H, Voigt JU, Froman M, Bone D. Wranne B, Juhlin-Dannfeldt A. Interaction of microbubbles with ultrasound. Echocardiography 1999; 16:733—41.
12. von Bibra H, Bone D, Niklasson U, Eurenius L, Hansen A. Myocardial contrast echocardiography yields best accuracy using quantitative analysis of digital data from pulse inversion technique - comparison with second harmonic imaging. Eur J Echocardiography 2002;3:271-82.
13. von Bibra H. Enhancement of Doppler Echocardiography. In: Goldberg B, Raichlen J, Fors-berg F (eds.). Ultrasound Contrast Agents: Basic Principles and Clinical Practice. London: Dunitz Publishers 2001; pp. 227-36.
14. Bin .IP, Pelberg RA, Wei K, Le DE, Goodman NC, Kaus S. Dobutamine versus dipyridamole for inducing reversible perfusion defects in chronic multivessel coronary artery stenosis. J Am Coll Cardiol 2002;40:167-74.
15. Bums PN, Powers JE, Simpson DH, Uhlendorf V, Fritzsche T. Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996;51 (Suppi 1):50-5.
16. Caiati C, Aragona P, Iliceto S, Rizzon P. Improved Doppler detection of proximal left anterior descending coronary artery stenosis after intravenous injection of a lung crossing contrast agent: A transesophageal Doppler echocardiographic study. J Am Coll Cardiol 1996;27; 1413—21.
17. Caiati C, Montaldo C, Zedda N, Bina A, Iliceto S. New noninvasive method for coronary flow reserve assessment - Contrast-enhanced transthoracic second harmonic echo Doppler. Circulation 1999;97:771-8.
18. Crouse LJ, Cheirif J, Hanly DE et al. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the phase 111 Albunex Multicenter Trial. .1 Am Coll Cardiol 1993;22:1494-1500.
19. Crowly JJ, Shapiro LM. Transthoracic echocardiographic measurement of coronary blood flow and reserve. J Am Soc Echocardiogr 1997; 10:337—43.
20. Dawson D, Rinkevich D, BelcikT et al. Measurement of myocardial blood flow velocity reserve with myocardial contrast echocardiography in patients with suspected coronary artery disease: comparison with quantitative gated technetium-99m sestamibi single-photon emission computer tomography. J Am Soc Echocardiogr 2003;16:1171-7.
21. Decara JM, Mor-Avi V, Weinert L et al. Automated quantitative assessment of wall motion in patients with poor acoustic windows. J Am Soc Echocardiogr 2004;17:723-731.
22. Dolan MS, Riad K, el-Shafei A et al. Effect of intravenous contrast for left ventricular opacification and border defintion on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients. Am Heart J 2001;142:908-15.
23. Dounis V, Siegmund T, Hansen A, Jensen J, Schumm-Draeger PM, von Bibra H. Global Myocardial Perfusion and Diastolic Function are Impaired to a Similar Extent in Patients with Type 2 Diabetes Mellitus and in Patients with Coronary Artery Disease - Evaluation by Contrast Echocardiography and Pulsed Tissue Doppler. Diabetologia 2006:49:2729-40.
24. Elhendy A, O’Leary EL, Xie F, McCain AC, Anderson JR, Porter TR. Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol 2004;44:2181-5.
25. Elhendy A, Tsutsui JM, O’Leary EL, Xie F, Mc-Gain AC, Porter TR. Noninvasive diagnosis of coronary artery disease in patients with diabetes by dobutamine stress real-time myocardial contrast perfusion imaging. Diabetes Care 2005;28:1662-7.
26. Erbel R, Schweizer P, Lambertz H et al. Echo-ventriculography - a simultaneous analysis of two-dimensional echocardiography and cineventriculography. Circulation 1983;67:205-215.
27. Feinstein SB, Ten Cate FJ, Zwehl W et al. Two-dimensional contrast echocardiography. I. In vitro development and quantitative analysis of echo contrast agents. .1 Am Coll Cardiol 1984;3:14-20.
28. Feinstein SB, Cheirif J, Ten Cate F et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: Initial multicenter clinical results. J Am Coll Cardiol 1990:16:316-324.
29. Firschke C, Koberl B, von Bibra H, Horcher J, Schomig A. Combined use of contrast enhanced 2-dimensional and color Doppler echocardiography for improved left ventricular endocardial border delineation using Levovist a new venous echocardiographic contrast agent. Int J Card Imaging 1997;13:137-144.
30. Fisher DC, Fischer EA, Budd JH, Rosen SE, Goldman ME. The incidence of patent foramen ovale in 1000 consecutive patients. A contrast transesophageal echocardiographic study. Chest 1995;107:1504-1509.
31. Grayburn P, Weiss J, Hack T et al. Phase 111 Multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with sub-optimal echocardiograms. J Am Coll Cardiol 1998;32:230-6.
32. Grill HP, Brinkner JA, Tanbe J et al. Contrast echocardiographic mapping of collateralized myocardium in humans before and after coronary angioplasty. J Am Coll Cardiol 1990;16:1594-1600.
33. Hagendorff A, Gockritz A, Wunderlich A, Frigstad S, Pfeiffer D, Becher H. Determinants of myocardial hypoperfusion analyzed for the interventricular septum using power Doppler harmonic imaging with contrast echocardiography in humans: a methodological approach for clinical practice. J Am Soc Echocardiogr 2002;15:404-16.
34. Hansen A, Johansson BL, Wahren J, von Bibra H. С-Peptide Exerts Beneficial Effects on Myocardial Blood Flow and Function in Patients With Type 1 Diabetes. Diabetes 2002;51:3077-82.
35. Hausmann D, Miigge A, Daniel WG. Identification of patent foramen ovale permitting paradoxical embolism. J Am Coll Cardiol 1996;26:1030-8.
36. Hoffmann R, von Bardeleben S, Ten Cate F et al. Assessment of systolic left ventricular function: a multi-centre comparison of cineventriculography, cardiac magnetic resonance imaging, un-enhanced and contrast-enhanced echocardiography. Eur Heart J 2005;26:607-16.
37. Hope Simpson D, Ting Chin C, Burns PN. Pulse inversion Doppler: A new method for detecting nonlinear echoes from microbubble contrast agents. IEEE Transactions UFFC 1999;46:372-82.
38. Hundley WG, Kizilbash AM. Afridi 1 et al. Administration of an intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with Cine Magnetic Resonance Imaging. J Am Coll Cardiol 1998;32:230-6.
39. Ito H, Okamura A, Masayuama T et al. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute myocardial infarction. Circulation 1998;93:1993-9.
40. de Jong N. Physics of microbubble scattering. In: Nanda N, Schlief R, Goldberg В (eds.). Advances in Echo Imaging using contrast enhancement. Dordrecht: Kluwer Academic 1997; pp. 39-64.
41. Karap O, Lepper W, Vanoverschelde JL et al. Serial evaluation of perfusion defects in patients with a first acute myocardial infarction referred for primary PTCA using intravenous contrast echocardiography. Eur Heart .1 2001 ;22:1485-95.
42. Kaul S. Myocardial Contrast Echocardiography - 15 years of research and development. Circulation 1997;96:3745-60.
43. Kaul S. Assessing myocardial perfusion after attempted reperfusion. Should we bother? Circulation 1998;98:625-7.
44. Lambertz Н, Schuhmacher U, Tries HP, Stein T. Improvement of pulmonary venous flow Doppler signal after intravenous injection of Levovist. J Am Soc Echocardiogr 1997;10:891-8.
45. Lambertz H, Lethen H, Tries HP, Kersting S. Noninvasive measurement of coronary flow reserve - valuable functional information in cardiac workload. Ultraschall Med 2004;25:25-33.
46. Lang RM, Feinstein SB, Feldmann T, Neumann A, Gee Chua K, Borrow KM. Contrast echocardiography for evaluation of myocardial perfusion: effects of coronary angioplasty. J Am Coll Cardiol 1986;8:232-5.
47. LeightonTG. The acoustic bubble. London: Academic Press 1994; pp. 67-1428.
48. Leong-Poi H, Rim SJ, Fisher NG, Wei K, Kaul S. Perfusion versus function: the ischemic cascade in demand ischemia: implications of singlevessel versus multivessel stenosis. Circulation 2002;105:987-2.
49. Lepper W, Franke A, von Bibra H et al. SHU 508A (Levovist) enhanced doppler echocardiography improves the assessment of valvular heart disease. Echocardiogr 2001; 18: 363-72.
50. Lim TK, Janardhanan R. Burden L et al. Improved accuracy of low power contrast echocardiography for the assessment of left ventricular remodelling compared to unenhanced harmonic echocardiography following acute myocardial infarction: Comparison with cardiac magnetic resonance imaging. J Am Soc Echocardiogr 2005;18:1203-7.
51. Main ML, Aher CR, Rubin DN et al. Comparison of tissue harmonic imaging with contrast echocardiography and Doppler myocardial imaging for enhancing endocardial border resolution. Am J Cardiol 1999;83:218-22.
52. Malhotra V, Nwogu J, Bondmass MD et al. Is the technically limited echocardiographic study an endangered species? Endocardial border definition with native tissue harmonic imaging and Optison contrast: a view of 200 cases. J Am Soc Echocardiogr 2000; 13:771-3.
53. Malm S, Frigstad S, Sagberg E, Larsson H, Skjaerpe T. Acute and reproduciable measurement of left ventricular volume and ejection fraction by contrast echocardiography: a comparison with magnetic resonance imaging. J Am Coll Cardiol 2004;44:1030-5.
54. Medwin H. Counting bubbles acoustically: a review. Ultrasonics 1977;15:17-23.
55. Moir S, Haluska BA, Jenkins C, Fathi R, Marwick TH. Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease. Circulation 2004;! 10:1108-13.
56. Moore CA, Schmucker ML, Kaul S. Myocardial contrast echocardiography in humans. 1. Safety - A comparison with routine coronary arteriography. J Am Coll Cardiol 1986;8:1066-72.
57. Mor-Avi V, Bednarz J, Weinert L, Sugeng L, Lang RM. Power Doppler imaging as a basis for automated endocardial border detection during left ventricular contrast enhancement. Echocardiography 2000:17:529-37.
58. Nakatani S, Imanushu T, Terasawa A, Beppu S. Nagata S, Miyatake K. Clinical application of transpulmonary contrast-enhanced Doppler technique in the assessment of severity of aortic stenosis. J Am Coll Cardiol 1992;20:973-8.
59. Okayama H, Sumimoto T, Hiasa G, Morioka N, Yamamoto K, Kawada H. Usefulness of an echo-contrast agent for assessment of coronary flow velocity and coronary flow velocity reserve in the left anterior descending coronary artery with transthoracic Doppler scan echocardiography. Am Heart J 2002;143:668-75.
60. Peltier M, Vancraeynest D, Pasquet A et al. Assessment of the physiologic significance of coronary artery disease with dipyridamole realtime myocardial contrast echocardiography. Comparison with technetium-99m sestamibi single-photon emission computer tomography and quantitative coronary angiography. J Am Coll Cardiol 2004;43:257-64.
61. Perez de Isla L, Rodrigo JL, Almeria C, Perez Ferro M, Serra V, Zamorano JL. Myocardial contrast echocardiography in coronary artery disease. Eur J Echocardiogr 2004;5 Suppl 2:11-6.
62. Porter TR, Xie F, Kricsfeld A, Chiou A, Dabe-stani A. Improved endocardial border resolution during dobutamine stress echocardiography with intravenous sonicated dextrose albumin. J Am Coll Cardiol 1994;23:1440-3.
63. Porter T, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles. Circulation 1995;92:2391-5.
64. Radvan J, Marwick TH, Williams MJ, Camici P. Evaluation of the extent and timing of the coronary hyperemic response to Dipyridamole: A study with transesophageal echocardiography and positron emission tomography with oxygen 15 water. J Am Soc Echocardiogr 1995;8;864-73.
65. Rainbird AJ, Mulvagh SL, Oh JK al. Contrast dobutamine stress echocardiography; Clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr 2001; 14:378—85.
66. Reilly JP, Tunick PA, Timmerman RJ, Stein B, Rosenzweig BP, Kronzon I. Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients. J Am Coll Cardiol 2000;35:485-90.
67. Rinkevich D, Kaul S, WangXQ et al. Regional left ventricular perfusion and function in patients with chest pain presenting to the emergency department with chest pain and no ST-segment elevation. Eur Heart J 2005;26:1606-11.
68. Rovai D, Dini FL, dell’Anna R, Micheli A, Michelassi C. Impact of blunted pulmonary venous flow on the outcome of patients with left ventricular systolic dysfunction secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 2000;85:1455-1460.
69. Sabia PJ. Powers ER, Ragosta M et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992;327:1825-31.
70. Schlief R, Staks T, Mahler M, Rufer M, Fritzsch T, Seifert W. Successful opacification of the left heart chambers on echocardiographic examination after intravenous injection of a new saccharide based contrast agent. Echocardiography 1990;7:61-4.
71. Schrope B, Newhouse VL, Uhlendorf V. Simulated capillary blood flow measurement using a non-linear ultrasonic contrast agent. Ultrason Imaging 1990;14:134-58.
72. Senior R, Andersson O, Caidahl К et al. Enhanced left ventricular delineation with an intravenous injection of Sonovue, a new echocardiographic contrast agent: a European multicentre clinical trial. Echocardiography 2000;17:705-11.
73. Shimoni S, Frangogiannis NG, Aggeli CJ et al. Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction. Implications for the assessment of myocardial hibernation. Circulation 2002;106:950-6.
74. Skyba D, Camarano G, Goodman NC, Price RJ, Skalak TC, Kaul S. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection. J Am Coll Cardiol 1996;28:1292— 1300.
75. Spencer KT, Bednarz J, Mor-Avi V et al. Automated endocardial border detection and evaluation of left ventricular function from contrast enhanced images using modified acoustic quantifica-tion. J Am Soc Echocardiogr 2002;15:777-81.
76. Sun JP, Stewart WJ, Hanna J, Thomas JD. Diagnosis of patent foramen ovale by contrast versus color Doppler by transesophageal echocardiography: relation to atrial size. Am Heart J 1996;131:239-44.
77. Sutherland GR, Stewart MJ, Groundstroem KW et al. Color Doppler Myocardial Imaging: A new technique for the assessment of myocardial function. .1 Am Soc Echocardiography 1994;7:441-58.
78. Ten Cate FJ, Widimsky P, Cornel HJ, Waldstein DJ, Serruys P, Waaler A. Intracoronary Albunex: its effect on left ventricular hemodynamics, function and coronary sinus flow in humans. Circulation 1993;88:2123-7.
79. Teresawa A, Miyatake K, Nakatani S, Yamagishi M, Matsuda H, Beppu S. Enhancement of Doppler flow signals in the left heart chambers by intravenous injection of sonicated albumin. J Am Coll Cardiol 1993;21:737-42.
80. Tiemann K, Becher H, Bimmel D, Schlief R, Nandan N. Stimulated acoustic emission - nonbackscatter contrast effect of microbubbles seen with harmonic power Doppler imaging. Echocardiography 1997;14:65-70.
81. Tiernan K, Lohmeier S, Kuntz S et al. Real-time contrast echo assessment of myocardial perfusion at low emission power. Echocardiography 1999;16:799-809.
82. Timperley J. Mitchell A, Blackman D et al. Semi-automatic boundary detection to improve reporting of regional left ventricular function. Eur J Echocardiogr 2006;7:209-16.
83. Toledo E, Jacobs L, Lodato J et al. Quantitative diagnosis of stress induced myocardial ischemia using analysis of contrast echocardiographic parametric perfusion images. Eur J Echocardiogr 2006;7:217-25.
84. Tuchnitz A, von Bibra H, Sutherland GR. Erhardt W, Henke J, Schomig A. Doppler energy, a new acquisition technique for the transthoracic detection of myocardial perfusion defects using a venous contrast agent. J Am Soc Echocardiography 1997;10:881-90.
85. Tsutsui ,IM, Elhendy A, Anderson JR, Xie F, McGrain AC, Porter TR. Prognostic value ofdobutamine stress myocardial contrast perfusion echocardiography. Circulation 2005; 112:1444-50.
86. Tsutsui JM, Xie F, McGrain AC et al. Comparison of low-mechanical index pulse sequence schemes for detectiong perfusion abnormalities during vasodilator stress echocardiography. Am J Cardiol 2005;95:565-70.
87. Valdez-Cruz LM, Sahn DJ. Ultrasonic contrast studies for the detection of cardiac shunts. J Am Coll Cardiol 1984;3:978-85.
88. Voci P, Bilotta F, C’aretta Q, Chiarotti F, Mer-cantini C, Marino B. Mechanisms of incomplete cardioplegia distribution during coronary artery surgery. Anesthesiology 1993;79:904-12.
89. Voigt JU, Temmen KW, Werner D, von Bibra H, Nixdorff U, Daniel WG. Verfalscht die Atmung die Messung myokardialer Signalintensitaten bei Echokontrastmitteluntersuchungen? Biomed Tech 2000;45(Suppl 1):67—8.
90. Walpoth BH, Muller MF, Genyk I et al. Evaluation of coronary bypass flow with color Doppler and magnetic resonance imaging techniques: comparison with intraoperative flow measurements. Eur J Cardio Thoracic Surgery 1999;15:795-802.
91. Wei K., Skyba D, Firschke C, Jayaweera A, Lindner J, Kaul S. Interactions between microbubbles and ultrasound in vitro and in vivo observations. J Am Coll Cardiol 1997;29:1081-8.
92. Wei K, Crouse L, Weiss J et al. Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99m estamibi single-photon emission computed tomography for detection of coronary artery disease (PB127 Multicenter Phase 2 Trial results). Am J Cardiol 2003;91:1293-8.
93. Wiewall-Winkelmann J, Jill Block R, Feinstein S. Usefulness of echo enhancement in stress echocardiography (USA experience). In: Nan-da N, Schlief R, Goldberg В (eds.). Advances in echo imaging using contrast enhancement. Dordrecht: Kluwer Academic Publishers 1997; pp. 361-70.
94. Yamaha S, Komuro K, Mikami T et al. Novel quantitative assessment of myocardial perfusion by harmonic power Doppler imaging during myocardial contrast echocardiography. Heart 2005;91:183-8.
95. Yano A, Ito H, Iwakura К et al. Myocardial contrast echocardiography with a new calibration method can estimate myocardial viability in patients with myocardial infarction. J Am Coll Cardiol 2004;43:1799-806.
96. Yong Y. Wu D. Fernandes V et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol 2002;89:711-8.
97. Yu EH, Sloggett CE, Iwanochko RM, Rakowski H, Siu SC. Feasibility and accuracy of left ventricular volumes and ejection fraction. Determination by fundamental, tissue harmonic and intravenous contrast imaging in difficultto-image patients. .1 Am Soc Echocardiogr 2000;13:216-22.
98. Yu EH, Skyba DM, Leong-Poi H et al. Incremental value of parametric quantitative assessment of myocardial perfusion by triggered low-power myocardial contrast echocardiography. J Am Coll Cardiol 2004;43:1807-13.
99. Zhao BW, Mizushige K, Xian TC, Matsuo H. Incidence and clinical significance of interatrial shunting in patients with atrial septal aneurysm detected by contrast transesophageal echocardiography. Angiology 1999;50:745-53.
Список литературы использованной при подготовке статей по контрастной эхокардиографии миокарда:
1. Averkiou МА, Hamilton MF. Measurements of harmonic generation in a focused finite-amplitude sound beam. J Acoust Soc Am 1997:98: 3439-42.
2. Averkiou MA, Hamilton MF. Nonlinear distortion of short pulses radiated by plane and focused circular pistons. .1 Acoust Soc Am 1997; 102: 2539-48.
3. Becher H, Burns P. Handbook of Contrast Echocardiography. Heidelberg: Springer 2000.
4. Becher H, Chambers J, Fox К et al. British Society of Echocardiography Policy Committee. BSE procedure guidelines for the clinical application of stress echocardiography, recommendations for Performance and Interpretation of stress echocardiography: a report ot’the British Society of Echocardiography Policy Committee. Heart 2004;90(Suppl 6):vi23-30.
5. Becher H, Lofiego C, Mitchell A, Timperley J. Current indications for contrast echocardiography imaging. Eur J Echocardiogr 2005; 6(Suppl2):S 1—5.
6. Becher H, Tiemann K, Powers J. Power Harmonic Imaging - clinical application in contrast echocardiography. Medica Mundi I999;43(2): 26-30.
7. Becher H, Tiemann K, Schlief R, Nanda N. Harmonic Power Doppler Contrast Echocardiography: preliminary clinical results. Echocardiography 1997; 14(6):631-42.
8. Becher H, Tiemann K, Schlosser T et al. Improvement of endocardial border delineation using tissue harmonic imaging. Echocardiography 1998; 15(5):511-6.
9. Becher H. Power Doppler. In Rush-Presbyterian-St. Luke Clinical Use of Contrast Echocardiography. Am J Cardiol - a continuing education 1998.
10. Burns PN, Powers JE, Fritzsch T. Harmonic imaging, a new imaging and Doppler method for contrast enhanced ultrasound. Radiology 1992; 185:142A.
11. Burns PN. Powers JE, Hope Simpson D et al. Harmonic power mode Doppler using microbubble contrast agents: an improved method for small vessel flow imaging. Proc IEEE UFFC 1994; 1547-50.
12. Dijkmans PA, Senior R, Becher H, Porter TR, Wei K, Ramp O. Myocardial contrast echocardiography: the future technique for accurate, quick, and safe assessment of myocardial perfusion? JACC 2006.
13. Elhendy A, O'Leary EL, Xie F, McGrain AC, Anderson JR, Porter TR. Comparative accuracy of real-time myocardial contrast perfusion imaging and wall motion analysis during dobutamine stress echocardiography for the diagnosis of coronary artery disease. J Am Coll Cardiol 2004;44:2185-91.
14. Hope-Simpsson D, Chin CT, Burns PN. Pulse Inversion Doppler: A new method for detecting nonlinear echoes from microbubble contrast agents. IEEE Transactions UFFC 1999;46:376-82.
15. Kaul S. Myocardial contrast echocardiography. 15 years of research and development. Circulation 1997;96:3745-60.
16. Linka AZ, Sklenar J, Wei K, Jayaweera AR, Skyba DM, Kaul S. Assessment of transmural distribution of myocardial perfusion with contrast echocardiography. Circulation 1998;98: 1912-20.
17. Moir S, Haluska BA, Jenkins C, Fathi R, Marwick TH. Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease. Circulation 2004;110:1108-13.
18. Mulvagh SL, DeMaria AN, Feinstein SB et al. ASE Position Paper. Contrast Echocardiography: Current and future applications. J Am Soc Echocardiogr 2000; 13:331^12.
19. Porter TR, Xie F. Transient myocardial contrast after initial exposure to diagnostic ultrasound pressures with minute doses of intravenously injected microbubbles: demonstration and potential mechanisms. Circulation 1995;92:2391-5.
20. Schwarz KQ, Chen X, Steinmetz S, Phillips D. Harmonic Imaging with Levovist. J Am Soc Echocardiogr 1997;10:1-10.
21. Shimoni S, Frangogiannis NG, Aggeli CJ et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation 2003; 107:538-44.
22. Spencer KT, Bednarz J, Mor-Avi V et al. The role of echocardiographic harmonic imaging and contrast enhancement for improvement of endocardial border delineation. .1 Am Soc Echocardiogr 2000; 13:131-8.
23. Thanigaraj S, Schlechtman KB, Perez JE. Improved echocardiographic delineation of left ventricular thrombus with use of intravenous second-generation contrast image enhancement. J Am Soc Echocardiogr 1999;12:1022-6.
24. Thomas JD, Rubin DN. Tissue Harmonic Imaging: why does it work? J Am Soc Echocardiogr 1998;11:803-8.
25. Tiemann K, Becher H, Bimmel D, Schlief R, Nanda N. Stimulated acoustic emission. Non-backscatter contrast effect of microbubbles seen with harmonic power Doppler imaging. Echocardiography 1997;14:65-9.
26. Tiemann K, Lohmeier S, Kuntz S et al. Real-time contrast echo assessment of myocardial perfusion at low emission power: First experimental and clinical results using power pulse inversion imaging. Echocardiography 1999;16:799-809.
27. Tsutsui JM, Elhendy A, Anderson JR, Xie F, McGrain AC, Porter TR. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 2005;112:1444-50.
28. van der Wouw PA, Brauns AC, Bailey SE et al. Premature ventricular contractions during imaging with ultrasound contrast. J Am Soc Echocardiogr 2000;13:288-94.
29. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-83.
30. Wei K, Le E, Jayaweera AR, Bin JP, Goodman NC, Kaul S. Detection of noncritical coronary stenosis at rest without recourse to exercise or pharmacological stress. Circulation 2002; 105:218-23.
31. Xie F, Tsutsui JM, McGrain AC et al. Comparison of dobutamine stress echocardiography with and without real-time perfusion imaging for detection of coronary artery disease. Am J Cardiol 2005;96:506-11.
32. Yu E, Sloggett C, Iwanochko RM, Rakowski H, Siu S. Feasibility and accuracy of left ventricular ejection fraction determination by fundamental, tissue harmonic, and Levovist enhanced contrast imaging. J Am Soc Echocardiogr 2000;13: 216-24.
Список использованной литературы при подготовке статьи "Перспективы применения контрастной эхокардиографии":
1. Ay Т, Havaux X, Van Camp G et al. Destruction of Contrast Microbubbles by Ultrasound: Effects on Myocardial Function, Coronary Perfusion Pressure, and Microvascular Integrity. Circulation 2001; 104(4):461 —6.
2. Bekeredjian R, Chen S, Frenkel PA, Graybum PA, Shohet RV. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003; 108(8): 1022-6.
3. Bekeredjian R, Chen S, Grayburn PA, Shohet RV. Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol 2005;31 (5):687-91.
4. Bekeredjian R, Chen S, Pan W, Grayburn PA, Shohet RV. Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med Biol 2004;30(4):539-43.
5. Brujan EA. The role of cavitation microjets in the therapeutic applications of ultrasound. Ultrasound Med Biol 2004;30(3):381 —7.
6. Chen S, Shohet RV, Bekeredjian R, Frenkel P, Grayburn PA. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003;42(2):301-8.
7. Christiansen .IP, Leong-Poi H, Klibanov AL, Kaul S, Lindner JR. Noninvasive Imaging of Myocardial Reperfusion Injury Using Leukocyte-Targeted Contrast Echocardiography. Circulation 2002; 105(15): 1764-7.
8. Cohen MG, Tuero E, Bluguermann .1 et al. Transcutaneous ultrasound-facilitated coronary thrombolysis during acute myocardial infarction. Am J Cardiol 2003;92(4):454-7.
9. Culp WC, Porter TR, McCowan TC et al. Microbubble-augmented Ultrasound Declotting of Thrombosed Arteriovenous Dialysis Grafts in Dogs. J Vase Interv Radiol 2003; 14(3):343—7.
10. Daffertshofer M, Huang Z, Fatar M et al. Efficacy of sonothrombolysis in a rat model of embolic ischemic stroke. Neuroscience Letters 2004;361 (1—3): 115-9.
11. Deng CX, Sieling F, Pan H, Cui J. Ultrasound-induced cell membrane porosity. Ultrasound Med Biol 2004;30(4):519-26.
12. Eggers J, Seidel G, Koch B, Konig IR. Sonothrombolysis in acute ischemic stroke for patients ineligible for rt-PA. Neurology 2005;64(6): 1052-4.
13. Fitzgerald PJ, Takagi A, Moore MP et al. Intravascular Sonotherapy Decreases Neointimal Hyperplasia After Stent Implantation in Swine. Circulation 2001; 103( 14): 1828-31.
14. Frenkel PA, Chen S, Thai T, Shohet RV, Grayburn PA. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med Biol 2002;28(6):817—22.
15. Guzman HR, McNamara AJ, Nguyen DX, Prausnitz MR. Bioeffects caused by changes in acoustic cavitation bubble density and cell concentration: a unified explanation based on cell-to-bubble ratio and blast radius. Ultrasound Med Biol 2003 ;29(8): 1211-22.
16. Imada T, Tatsumi T, Mori Y et al. Targeted Delivery of Bone Marrow Mononuclear Cells by Ultrasound Destruction of Microbubbles Induces Both Angiogenesis and Arteriogenesis Response. Arterioscler Thromb Vase Biol 2005;25(10):2128-34.
17. Kaul S, Senior R, Dittrich H, Raval U, Khattar R, Lahiri A. Detection of Coronary Artery Disease With Myocardial Contrast Echocardiography: Comparison With 99mTc-Sestamibi Single-Photon Emission Computed Tomography. Circulation 1997;96(3):785-92.
18. Kinoshita M. Hynynen K. A novel method for the intracellular delivery of siRNA using micro-bubble-enhanced focused ultrasound. Biochemical and Biophysical Research Communications 2005;335(2):393-9.
19. Li P, Cao LQ, Dou CY, Armstrong WF, Miller D. Impact of myocardial contrast echocardiography on vascular permeability: an in vivo dose response study of delivery mode, pressure amplitude and contrast dose. Ultrasound Med Biology 2003;29(9): 1341-9.
20. Lindner JR, Coggins MP, Kaul S, Klibanov AL, Brandenburger GH, Ley K. Microbubble Persistence in the Microcirculation During Ischemia/Reperfusion and Inflammation Is Caused by Integrin- and Complement-Mediated Adherence to Activated Leukocytes. Circulation 2000; 101 (6):668—75.
21. Lindner JR. Dayton PA, Coggins MPet al. Noninvasive Imaging of Inflammation by Ultrasound Detection of Phagocytosed Microbubbles. Circulation 2000; 102(5):531 —8.
22. Lindner JR, Song J, Xu F et al. Noninvasive Ultrasound Imaging of Inflammation Using Microbubbles Targeted to Activated Leukocytes. Circulation 2000; 102(22):2745-50.
23. Marmottant P, Hilgenfeldt S. Controlled vesicle deformation and lysis by single oscillating bubbles. Nature 2003;423(6936): 153-6.
24. Mehier-Humbert S. Bettinger T, Yan F, Guy RH. Ultrasound-mediated gene delivery: Kinetics of plasmid internalization and gene expression. J Control Release 2005; 104(1 ):203—11.
25. Miller DL, Quddus J. Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies. Ultrasound Med Biol 2000;26(4):661—7.
26. Mizuno Y, Iwata H, Takagi H et al. Sonoporation with doxorubicin enhances suppression of intimal hyperplasia in a vein graft model. J Surg Res 2005;124(2):312-7.
27. Mizushige K, Kondo I, Ohmori K. Hirao K. Matsuo II. Enhancement of ultrasound-accelerated thrombolysis by echo contrast agents: dependence on microbubble structure. Ultrasound Med Biol 1999;25(9): 1431-7.
28. Mukherjee D, Wong J, Griffin В et al. Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J Am Coll Cardiol 2000;35(6): 1678-86.
29. Price RJ, Skyba DM, Kaul S, Skalak TC. Delivery of Colloidal Particles and Red Blood Cells to Tissue Through Microvessel Ruptures Created by Targeted Microbubble Destruction With Ultrasound. Circulation 1998;98( 13): 1264-7.
30. Schlosser T, Pohl C, Kuntz-Hehner S, Omran H. Becher H, Tiemann K. Echoscintigraphy: a new imaging modality for the reduction of color blooming and acoustic shadowing in contrast sonography. Ultrasound Med Biol 2003;29(7):985—91.
31. Schlosser T, Pohl C, Veltmann C et al. Feasibility of the flash-replenishment concept in renal tissue: which parameters affect the assessment of the contrast replenishment? Ultrasound Med Biol 2001;27(7):937^14.
32. Schumann P, Christiansen JP, Quigley R et al. Targeted-microbubble binding selectively to GPllb 111a receptors of platelet thrombi. Invest Radiol 2002;37(11 ):587-93.
33. Shohet RV, Chen S, Zhou YT et al. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000; 101 (22):2554-6.
34. Skyba DM, Price RJ, Linka AZ, Skalak TC, Kaul S. Direct In Vivo Visualization of Intravascular Destruction of Microbubbles by Ultrasound and its Local Effects on Tissue. Circulation 1998;98(4):290-3.
35. Song J, Qi M, Kaul S, Price RJ. Stimulation of Arteriogenesis in Skeletal Muscle by Microbubble Destruction with Ultrasound. Circulation 2002; 106( 12): 1550-5.
36. Stride E, Saffari N. On the destruction of microbubble ultrasound contrast agents. Ultrasound Med Biol 2003;29(4):563-73.
37. Sundaram J, Mellein BR, Mitragotri S. An Experimental and Theoretical Analysis of Ultrasound-Induced Permeabilization of Cell Membranes. Biophys J 2003;84(5):3087-101.
38. Tachibana K, Tachibana S. Albumin Microbubble Echo-Contrast Material as an Enhancer for Ultrasound Accelerated Thrombolysis. Circulation 1995;92(5): 1148-50.
39. Teupe C, Richter S, Fisslthaler В et al. Vascular gene transfer of phosphomimetic endothelial nitric oxide synthase (SI 177D) using ultrasound-enhanced destruction of plasmid-loaded microbubbles improves vasoreactivity. Circulation 2002; 105(9): 1104-9.
40. Tiemann K, Becher H. Myocardial contrast echocardiography. Research Instrument or already clinical application? Z Kardiol 2000;89( 10):903-5.
41. Tiemann K, Lohmaier S, Kuntz S et al. Real-Time Contrast Echo Assessment of Myocardial Perfusion at Low Emission Power: First Experimental and Clinical Results Using Power Pulse Inversion Imaging. Echocardiography 1999; 16(8):799-809.
42. Tiemann K, Schlosser T, Pohl C et al. Are microbubbles free flowing tracers through the Myocardium? Comparison of indicator-dilution curves obtained from dye dilution and echo contrast using harmonic power Doppler imaging. Echocardiography 2000; 17(1): 17-27.
43. Tsunoda S, Mazda O, Oda Y et al. Sonoporation using microbubble BR14 promotes pDNA/ siRNA transduction to murine heart. Biochem Biophys Res Com 2005;336(1): 118—27.
44. Villanueva FS, Jankowski RJ, Klibanov S et al. Microbubbles Targeted to Intercellular Adhesion Molecule-1 Bind to Activated Coronary Artery Endothelial Cells. Circulation 1998;98(1): 1—5.
45. Ward M, Wu J, Chiu JF. Experimental study of the effects of optison (R) concentration on sonoporation in vitro. Ultrasound Med Biol 2000;26(7): 1169-75.
46. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of Myocardial Blood Flow With Ultrasound-Induced Destruction of Microbubbles Administered as a Constant Venous Infusion. Circulation 1998;97(5):473—83.
47. Wei К, Le Е, Bin JP, Coggins M, Thorpe J, Kaul S. Quantification of renal blood flow with contrast-enhanced ultrasound. J Am Coll Cardiol 2001 ;37(4): 1135-40.
48. Weller GER, Lu E, Csikari MM et al. Ultrasound Imaging of Acute Cardiac Transplant Rejection With Microbubbles Targeted to Intercellular Adhesion Molecule-1. Circulation 2003; 108(2):218-24.
49. Yoshida J, Ohmori K, Takeuchi H et al. Treatment of Ischemic Limbs Based on Local Recruitment of Vascular Endothelial Growth Factor-Producing Inflammatory Cells With Ultrasonic Microbubble Destruction. Journal of the American College of Cardiology 2005;46(5):899-905.
